心肌纤维化在功能性二尖瓣反流中的重要性:从结局到决策
本文综述心脏磁共振(CMR)对功能性二尖瓣反流(FMR)患者的综合评估价值,重点阐述心肌纤维化(MF)评估如何补充风险分层并影响治疗决策。FMR severity 与风险相关但受潜在左心室病变调节,CMR 评估 MF 可能为临床决策提供增量信息。
要点
- FMR 的风险随反流严重度增加,但受潜在左心室病变调节。
- CMR 可综合评估 FMR 患者,其中心肌纤维化评估可能补充风险分层。
- CMR 评估心肌纤维化可能对 FMR 临床决策产生影响。
关键影像表现/征象
- FMR 的严重度与风险增加相关,但风险受潜在左心室病变调节。
- 左心室重构与功能障碍的程度传统上通过超声心动图评估。
- 越来越多证据显示,CMR 评估心肌纤维化可能补充风险分层并为治疗决策提供信息。
临床应用与阅片要点
- 作者指出,CMR 评估心肌纤维化可能补充 FMR 的风险分层并为治疗决策提供信息。
- 作者建议在 FMR 患者中综合应用 CMR 评估,尤其关注心肌纤维化,以辅助临床决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Functional mitral regurgitation (FMR) is a common and complex valve disease, in which severity and risk stratification is still a conundrum. Although risk increases with FMR severity, it is modulated by subjacent left ventricular (LV) disease. The extent of LV remodeling and dysfunction is traditionally evaluated by echocardiography, but a growing body of evidence shows that myocardial fibrosis (MF) assessment by cardiac magnetic resonance (CMR) may complement risk stratification and inform treatment decisions. This review summarizes the current knowledge on the comprehensive evaluation that CMR can provide for patients with FMR, in particular for the assessment of MF and its potential impact in clinical decision-making.
引用
- Lopes BBC, Kwon DH, Shah DJ, et al. Importance of Myocardial Fibrosis in Functional Mitral Regurgitation: From Outcomes to Decision-Making. JACC Cardiovasc Imaging. 2021. PMID: 33582069. doi:10.1016/j.jcmg.2020.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。